Pfizer to spend $120 million to boost U.S. COVID pill manufacturing

This post was originally published on this site

Use of the pill, Paxlovid, authorized to treat newly infected, at-risk people to prevent severe illness, has soared recently as infections rise.

Biden administration officials have pushed for the wider use of Paxlovid, which the government distributes for free.